UPB CJC/IPA 5MG/5MG without DAC
US$ 20.50
foxo4 dri human clinical trial FOXO4-DRI 10mg senescence research foxo4-dri peptide human clinical trial
Description
RegeneRx Biopharmaceuticals
BPC-157 is a peptide that has shown promise in promoting healing and reducing inflammation in animal studies
Histochem Cytochem 63 , 575591 (2015)
Both are taken as capsules
Although it is a derivative of hGH, it does not act via the GH receptor (GHR)
